Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Turkish Journal of Medical Sciences|December 14, 2020
Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in TurkeyNur Soyer, Rıdvan Ali, Mehmet Turgut, et al.Clinical Lymphoma, Myeloma & Leukemia|June 3, 2020
Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory MyelomaMeral Beksac, Yildiz Aydin, Hakan Goker, et al.Leukemia & Lymphoma|April 10, 2020
Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myelomaKatja Weisel, Meletios Dimopoulos, Philippe Moreau, et al.Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|October 22, 2019
Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort StudyMüfide Okay, Tuncay Aslan, Evren Özdemir, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 21, 2017
Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG)Emre Tekgündüz, Fatih Demirkan, Filiz Vural, et al.European Journal of Haematology|September 8, 2021
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristicsPaul G Richardson, Fredrik Schjesvold, Katja Weisel, et al.JAMA|July 10, 2019
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical TrialAdriana Bastidas, Javier de la Serna, Mohamed El Idrissi, et al.Human Vaccines & Immunotherapeutics|August 18, 2021
Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practiceEdward A Stadtmauer, Keith M Sullivan, Mohamed El Idrissi, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 1, 2019
The Turkish experience with therapeutic plasma exchange: A national surveySerdal Korkmaz, Serife Solmaz Medeni, Fatih Demirkan, et al.Pageof 6